Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5869 posts found.

takeda_usa_pharmaceuticals_u

Takeda to create 70 jobs with €25m Dublin investment

March 1, 2018 Manufacturing and Production Dublin, Takeda, pharma

Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …
News
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
News
nhs_sign

UK Government announces prescription price hike to record level

February 27, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …
News

Allergan’s patent gamble fails

February 27, 2018 Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical

Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …
News
opioid_crisis

FDA to fight opioid crisis with wider access to medication-assisted treatment

February 27, 2018 Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma

The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …
News
vaccination-2722937_960_720

UK govt report looks to reduce vaccination spending

February 27, 2018 Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical

One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …
News

FDA expands indication of Lilly’s Verzenio in advanced breast cancer

February 27, 2018 Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma

Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease

It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …
News
aaa

Insider Interview: Allergan’s R&D Chief on plans to be “the headache company”

February 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, David Nicholson, Insider Interview, migraine, pharma

Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …
Feature

NICE recommends thyroid cancer drug trio for NHS use

February 20, 2018 Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …
News
business_generic

Shire, Microsoft and EURORDIS form rare disease alliance

February 20, 2018 Manufacturing and Production, Research and Development Microsoft, Shire, eurordis, pharma, rare disease

Rare disease specialist pharma firm Shire, rare disease patient alliance EURORDIS and tech giant Microsoft have announced they have formed …
News
flu_virus

Low flu vaccine efficacy may be due to previous immune history, study finds

February 20, 2018 Manufacturing and Production, Research and Development H3N2, Vaccine, flu, flue vaccine, influenza, pharma

The sometimes poor efficacy of influenza vaccines may be due to poor immune response and a patient’s wider immune history, …
News
shutterstock_138095450

Japan’s Oncolys invests £3m in adenovirus firm Unleash Immuno Oncolytics

February 20, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Oncolys, Unleash Immuno Oncolytics, pharma

Unleash Immuno Oncolytics, a US firm focusing on the development of viral biologics in the treatment of cancer, has attracted …
News
lilly_entrance_web

Lilly dumps Hanmi’s rheumatoid arthritis med

February 20, 2018 Manufacturing and Production, Sales and Marketing Eli Lilly, arthritis, hanmi, pharma

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, …
News
img_9530_resized

Patient experience: Living with multiple myeloma

February 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, mutiple myeloma, patient experience, pharma

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …
Feature
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026